AnswersNow, Inc.

Based in the US, AnswersNow, Inc. operates a digital platform providing virtual Applied Behavior Analysis (ABA) therapy services designed to support individuals with autism and their families. Founded in 2017 and headquartered in Richmond, US, AnswersNow, Inc. specializes in virtual ABA therapy for autism.

In January 2026, AnswersNow, Inc. raised USD 40 million in series B funding led by new investor HealthQuest Capital, with participation from returning investors OWL Ventures, Left Lane Capital and Blue Heron Capital.. Jeff Beck is the founder of the company. AnswersNow specializes in providing virtual Applied Behavior Analysis (ABA) therapy tailored for individuals with autism.

Their core offerings include personalized, evidence-based therapy delivered through a proprietary digital platform that facilitates flexible scheduling and accessibility from any location. By matching clients with highly qualified board-certified behavior analysts (BCBAs), AnswersNow aims to address the unique needs of each family, ensuring that care is both individualized and effective. This service is designed to support children and families across various geographical markets, making it accessible to families everywhere, particularly in areas with limited access to traditional in-person ABA services. AnswersNow generates revenue through a model that accommodates multiple forms of client engagement, including direct-to-consumer transactions for personalized therapy sessions.

Families initiate a service intake leading to an assessment that pairs clients with appropriate clinicians. Revenue is derived from service contracts encompassing varying frequencies of therapy sessions, which may be billed through accepted health insurance plans, including Medicaid. This structure supports comprehensive care, including one-on-one sessions, parent training, and ongoing support, tailored to meet the specific needs of each client. In January 2026, AnswersNow, Inc.

raised USD 40 million in series B funding led by investor HealthQuest Capital, with participation from OWL Ventures and Left Lane Capital. The company will use the funding to scale its platform and team, expand clinical staff, launch new service offerings, and enhance its technology.